Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Seattle Genetics, Inc. (SGEN)

« Back to company index

SGEN Chatter Timeline

Stock Ticker for SGEN

Most Active Tweeters for SGEN

UserTweets
@AmericanBanking 6
@TickerReport 5
@StockWatchHQ 4
@1MinuteStock 3
@TOWiU2 2

Recent Tweets for SGEN

Briefingcom @Briefingcom
$SGEN: Seattle Genetics and Astellas (ALPMY) announce that the FDA has accepted the BLA for the investigational... https://t.co/Q9DHth67rH
10:09am
pnani456 @pnani456
RT @MarketCurrents: $SGEN - FDA grants accelerated review for Seattle Genetics ADC for urothelial cancer https://t.co/xJPQlH0owD
8:09am
MarketCurrents @MarketCurrents
$SGEN - FDA grants accelerated review for Seattle Genetics ADC for urothelial cancer https://t.co/xJPQlH0owD
8:09am
trade_123456 @trade_123456
$SGEN - Seattle Genetics and Astellas Announce U.S. FDA Grants Priority Review for Enfortumab Vedotin Biologics https://t.co/quWabnM1Jq
8:09am
trade_123456 @trade_123456
$SGEN - Seattle Genetics & Astellas Announce U.S. FDA Grants Priority Review for Enfortumab Vedotin Biologics https://t.co/PE4WuNVoW3
8:09am
AmericanBanking @AmericanBanking
FY2022 EPS Estimates for Seattle Genetics, Inc. $SGEN Cut by Analyst https://t.co/Gkw4MbtWXx #stocks
2:09am
AmericanBanking @AmericanBanking
Piper Jaffray Companies Comments on Seattle Genetics, Inc.’s Q3 2019 Earnings $SGEN https://t.co/kiI75r0WP4 #stocks
1:09am
ConsumerFeed @ConsumerFeed
Brokerages Expect Seattle Genetics, Inc. $SGEN Will Post Quarterly Sales of $210.60 Million https://t.co/Z6GUGL8zkC
12:09am
StockWatchHQ @StockWatchHQ
RT @StockWatchHQ: Spectrum Pharmaceuticals $SPPI Board Of Directors To Vote On Seattle Genetics $SGEN Offer Early Next Week https://t.co/vq…
12:09am
StockWatchHQ @StockWatchHQ
Spectrum Pharmaceuticals $SPPI Board Of Directors To Vote On Seattle Genetics $SGEN Offer Early Next Week… https://t.co/KlWJ4lEuBX
September 15th 2019, 2:09pm
TickerReport @TickerReport
Seattle Genetics $SGEN Lifted to Outperform at Oppenheimer https://t.co/FqQI6JA2zH
September 15th 2019, 9:09am
ThisLincolnian @ThisLincolnian
Seattle Genetics $SGEN Lifted to Outperform at Oppenheimer https://t.co/tQJzDt8PEY
September 15th 2019, 9:09am
bbnsnews @bbnsnews
Seattle Genetics $SGEN Lifted to Outperform at Oppenheimer https://t.co/40MZwYqxFY
September 15th 2019, 9:09am
StockWatchHQ @StockWatchHQ
RT @StockWatchHQ: Where There's Smoke There's Fire_Celldex Therapeutics $CLDX To Confirm Buyout Offer From Seattle Genetics $SGEN, Talks Ha…
September 15th 2019, 2:09am
TickerReport @TickerReport
Piper Jaffray Companies Comments on Seattle Genetics, Inc.’s FY2022 Earnings $SGEN https://t.co/5a0Y6iGabd
September 15th 2019, 2:09am
StockWatchHQ @StockWatchHQ
Where There's Smoke There's Fire_Celldex Therapeutics $CLDX To Confirm Buyout Offer From Seattle Genetics $SGEN, Ta… https://t.co/sxTsvuZcAr
September 14th 2019, 4:09pm
TickerReport @TickerReport
Seattle Genetics $SGEN Cut to Strong Sell at BidaskClub https://t.co/1t88G0mXgW
September 14th 2019, 4:09pm
WatchlistN @WatchlistN
Zacks: Brokerages Anticipate Seattle Genetics, Inc. $SGEN to Announce -$0.37 Earnings Per Share https://t.co/HYglCAwVt7
September 14th 2019, 3:09am
dakotafinancial @dakotafinancial
$210.60 Million in Sales Expected for Seattle Genetics, Inc. $SGEN This Quarter https://t.co/bwelEpCfxo
September 14th 2019, 3:09am
ConsumerFeed @ConsumerFeed
Seattle Genetics $SGEN Upgraded to Outperform at Oppenheimer https://t.co/H1GgplRdO7
September 13th 2019, 4:09pm
dispatchtribune @dispatchtribune
Seattle Genetics $SGEN Downgraded by BidaskClub https://t.co/G0OcyxbtUx
September 13th 2019, 2:09pm
registrarjourn @registrarjourn
BidaskClub Downgrades Seattle Genetics $SGEN to Strong Sell https://t.co/x4rV5tcHnT
September 13th 2019, 2:09pm
EnterpriseLeade @EnterpriseLeade
BidaskClub Downgrades Seattle Genetics $SGEN to Strong Sell https://t.co/MQCNWWg8fy
September 13th 2019, 2:09pm
AmericanBanking @AmericanBanking
FY2022 EPS Estimates for Seattle Genetics, Inc. $SGEN Boosted by Piper Jaffray Companies https://t.co/IkeVLRKxFP #stocks
September 13th 2019, 7:09am
TickerReport @TickerReport
Seattle Genetics, Inc. $SGEN CEO Sells $1,945,491.76 in Stock https://t.co/9QwVoNBjsf
September 13th 2019, 4:09am
dailypoliticaln @dailypoliticaln
Seattle Genetics $SGEN Stock Rating Lowered by BidaskClub https://t.co/plANINI1LO
September 13th 2019, 1:09am
ProVesting @ProVesting
$SGEN: Oppenheimer Turns Bullish On Seattle Genetics, Says Optimism …: https://t.co/iMA1oGt10I
September 12th 2019, 1:09pm
Quantumup1 @Quantumup1
$SGEN upgraded to Outperform, PT raised to $82 at Oppenheimer https://t.co/xbrcXUO9T7
September 12th 2019, 8:09am
AmericanBanking @AmericanBanking
Seattle Genetics $SGEN Raised to Outperform at Oppenheimer https://t.co/vjxaPb9Vk7 #stocks
September 12th 2019, 8:09am
AnalystWire @AnalystWire
UPDATE: Oppenheimer Upgrades Seattle Genetics $SGEN to Outperform https://t.co/WtEAORIfV9
September 12th 2019, 6:09am
knockouttrader @knockouttrader
$SGEN got a nice little piece today as well...
September 12th 2019, 6:09am
AnalystWire @AnalystWire
Oppenheimer Upgrades Seattle Genetics $SGEN to Outperform https://t.co/WtEAORIfV9
September 12th 2019, 5:09am
stocknewstimes @stocknewstimes
Zacks: Analysts Expect Seattle Genetics, Inc. $SGEN Will Post Quarterly Sales of $210.60 Million https://t.co/jmhw083mKq
September 11th 2019, 5:09pm
TheMarketsDaily @TheMarketsDaily
-$0.37 Earnings Per Share Expected for Seattle Genetics, Inc. $SGEN This Quarter https://t.co/0LRRYDnTFN
September 11th 2019, 5:09pm
macondailynews @macondailynews
Seattle Genetics, Inc. $SGEN Expected to Announce Earnings of -$0.37 Per Share https://t.co/hr35FKvtP0
September 11th 2019, 5:09pm
TranscriptDaily @TranscriptDaily
Seattle Genetics, Inc. $SGEN Expected to Announce Quarterly Sales of $210.60 Million https://t.co/nqwkJhBFXz
September 11th 2019, 5:09pm
IncredibleTrade @IncredibleTrade
$SGEN hammer yesterday and a follow through today https://t.co/avExDTRpqh
September 11th 2019, 11:09am
LargeVoidBot @LargeVoidBot
Daily Reversal (09:54): $SGEN Last: 69.32; pHigh: 68.82; rVol: 0.576; pClose: 68.65; LOD: 68.2800; Perf: 1.0%
September 11th 2019, 9:09am
Gambiste1 @Gambiste1
RT @TOWiU2: @ohadhammer thx, 2 follow on Q: 1) therapeutic efficacy ADC vs. bispecific from $SGEN view: a) just "try something new", or…
September 11th 2019, 4:09am
TOWiU2 @TOWiU2
@ohadhammer thx, 2 follow on Q: 1) therapeutic efficacy ADC vs. bispecific from $SGEN view: a) just "try somethin… https://t.co/BEXbLnYHb2
September 11th 2019, 1:09am
AmericanBanking @AmericanBanking
Insider Selling: Seattle Genetics, Inc. $SGEN CEO Sells 28,472 Shares of Stock https://t.co/A0EwLyKAJe #stocks
September 10th 2019, 8:09pm
dakotafinancial @dakotafinancial
Insider Selling: Seattle Genetics, Inc. $SGEN CEO Sells 28,472 Shares of Stock https://t.co/CzCHMdWSSq
September 10th 2019, 8:09pm
InsiderAlertsIA @InsiderAlertsIA
$SGEN: New Insider Filing on President and CEO CLAY B SIEGALL: https://t.co/5fXlgJUJZI
September 10th 2019, 7:09pm
StockTexts @StockTexts
$SGEN Seattle Genetics, Inc. SEC Filing: Form 4 https://t.co/xjAh3ub67B
September 10th 2019, 7:09pm
insiderbuyings @insiderbuyings
$SGEN new insider selling: 28472 shares. https://t.co/7ZgigPuM5l
September 10th 2019, 7:09pm
confcalltran @confcalltran
Seattle Genetics's President and CEO just cashed-in 28,472 options https://t.co/nMkwXxx31h $SGEN
September 10th 2019, 7:09pm
TOWiU2 @TOWiU2
@ohadhammer how do you see $pirs / $sgen collaboration with regards to future ADC/bispecific developments?
September 10th 2019, 3:09pm
TickerReport @TickerReport
Comparing Seattle Genetics $SGEN & Cortexyme $CRTX https://t.co/FLUEEjsn9o
September 10th 2019, 4:09am
Gambiste1 @Gambiste1
RT @TEEELAZER: $SGEN FTFC's down so let's see how much further down it goes. week https://t.co/w82hxRque3 month https://t.co/1HC078hogF
September 9th 2019, 12:09am
TEEELAZER @TEEELAZER
$SGEN FTFC's down so let's see how much further down it goes. week https://t.co/w82hxRque3 month https://t.co/1HC078hogF
September 8th 2019, 8:09pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.